Beth L. Thurberg

5.7k total citations
77 papers, 3.6k citations indexed

About

Beth L. Thurberg is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Beth L. Thurberg has authored 77 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Physiology, 35 papers in Rheumatology and 23 papers in Molecular Biology. Recurrent topics in Beth L. Thurberg's work include Lysosomal Storage Disorders Research (59 papers), Glycogen Storage Diseases and Myoclonus (35 papers) and Trypanosoma species research and implications (17 papers). Beth L. Thurberg is often cited by papers focused on Lysosomal Storage Disorders Research (59 papers), Glycogen Storage Diseases and Myoclonus (35 papers) and Trypanosoma species research and implications (17 papers). Beth L. Thurberg collaborates with scholars based in United States, France and United Kingdom. Beth L. Thurberg's co-authors include M. W. O'CALLAGHAN, Tucker Collins, Priya S. Kishnani, Nina Raben, Ronald E. Gordon, Robert J. Mattaliano, Anne Chun-Hui Tsai, C A Vaccaro, Robert J. Desnick and Stuart H. Orkin and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Genes & Development.

In The Last Decade

Beth L. Thurberg

76 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth L. Thurberg United States 34 2.6k 1.3k 1.1k 848 667 77 3.6k
Deeksha Bali United States 36 2.1k 0.8× 2.1k 1.6× 937 0.8× 624 0.7× 883 1.3× 109 4.1k
Roseline Froissart France 27 2.1k 0.8× 646 0.5× 804 0.7× 781 0.9× 494 0.7× 90 2.8k
Maryam Banikazemi United States 20 3.6k 1.4× 1.3k 1.0× 531 0.5× 1.7k 2.0× 1.0k 1.5× 36 4.0k
Daniel Grinberg Spain 33 1.3k 0.5× 410 0.3× 1.6k 1.4× 405 0.5× 440 0.7× 180 3.3k
Carmelo Rodolico Italy 28 409 0.2× 370 0.3× 951 0.9× 239 0.3× 100 0.1× 123 2.1k
Pei‐Hsin Huang Taiwan 24 438 0.2× 226 0.2× 893 0.8× 172 0.2× 111 0.2× 54 1.9k
Philippe Latour France 28 559 0.2× 105 0.1× 733 0.7× 180 0.2× 151 0.2× 103 2.5k
Grazia M.S. Mancini Netherlands 28 507 0.2× 209 0.2× 1.2k 1.0× 186 0.2× 37 0.1× 79 2.7k
Shinji Hatakeyama Japan 23 857 0.3× 167 0.1× 1.6k 1.5× 174 0.2× 38 0.1× 45 2.6k
Filippo Pinto e Vairo Brazil 20 602 0.2× 177 0.1× 569 0.5× 211 0.2× 88 0.1× 111 1.4k

Countries citing papers authored by Beth L. Thurberg

Since Specialization
Citations

This map shows the geographic impact of Beth L. Thurberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth L. Thurberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth L. Thurberg more than expected).

Fields of papers citing papers by Beth L. Thurberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth L. Thurberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth L. Thurberg. The network helps show where Beth L. Thurberg may publish in the future.

Co-authorship network of co-authors of Beth L. Thurberg

This figure shows the co-authorship network connecting the top 25 collaborators of Beth L. Thurberg. A scholar is included among the top collaborators of Beth L. Thurberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth L. Thurberg. Beth L. Thurberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pederson, Bartholomew A., et al.. (2024). A novel siRNA targeting and delivery platform inhibits glycogen synthesis and reduces glycogen levels in skeletal and cardiac muscle in a mouse model of Pompe disease. Molecular Genetics and Metabolism. 141(2). 107994–107994. 2 indexed citations
2.
Jessel, Andreas, et al.. (2024). The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency. SHILAP Revista de lepidopterología. 2. 101888–101888. 2 indexed citations
3.
Thurberg, Beth L.. (2020). Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report. Molecular Genetics and Metabolism Reports. 24. 100626–100626. 10 indexed citations
4.
Ramaswami, Uma, Daniel G. Bichet, L. Clarke, et al.. (2019). Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial. Molecular Genetics and Metabolism. 127(1). 86–94. 24 indexed citations
5.
Politei, Juan, et al.. (2017). Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?. Molecular Genetics and Metabolism Reports. 11. 8–11. 15 indexed citations
6.
Thurberg, Beth L., et al.. (2016). Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies. Molecular Genetics and Metabolism Reports. 11. 75–80. 6 indexed citations
7.
Wasserstein, Melissa, Simon Jones, Handrean Soran, et al.. (2015). Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency. Molecular Genetics and Metabolism. 116(1-2). 88–97. 70 indexed citations
8.
McGovern, Margaret M., Melissa Wasserstein, Brian Kirmse, et al.. (2015). Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency). Genetics in Medicine. 18(1). 34–40. 46 indexed citations
9.
Yi, Haiqing, Elizabeth D. Brooks, Beth L. Thurberg, et al.. (2014). Correction of glycogen storage disease type III with rapamycin in a canine model. Journal of Molecular Medicine. 92(6). 641–650. 30 indexed citations
10.
11.
Hobson‐Webb, Lisa D., Alan D. Proia, Beth L. Thurberg, et al.. (2012). Autopsy findings in late-onset Pompe disease: A case report and systematic review of the literature. Molecular Genetics and Metabolism. 106(4). 462–469. 67 indexed citations
12.
Koeberl, Dwight D., Songtao Li, Jian Dai, et al.. (2011). β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease. Molecular Genetics and Metabolism. 105(2). 221–227. 40 indexed citations
13.
Berman, David M., et al.. (2011). Investigative pathology: leading the post-genomic revolution. Laboratory Investigation. 92(1). 4–8. 18 indexed citations
14.
Sun, Baodong, Songtao Li, Andrew Bird, et al.. (2010). Antibody formation and mannose‐6‐phosphate receptor expression impact the efficacy of muscle‐specific transgene expression in murine Pompe disease. The Journal of Gene Medicine. 12(11). 881–891. 24 indexed citations
15.
Douillard‐Guilloux, Gaëlle, Nina Raben, Shoichi Takikita, et al.. (2009). Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease. Human Molecular Genetics. 19(4). 684–696. 49 indexed citations
16.
Young, Sarah P., Haoyue Zhang, Deyanira Corzo, et al.. (2009). Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genetics in Medicine. 11(7). 536–541. 72 indexed citations
17.
Rouleau, Cécile, William Weber, Robert Smale, et al.. (2008). Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma. Clinical Cancer Research. 14(22). 7223–7236. 86 indexed citations
18.
Crispino, John D., Maya Lodish, Beth L. Thurberg, et al.. (2001). Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes & Development. 15(7). 839–844. 242 indexed citations
19.
Thurberg, Beth L., Paul H. Duray, & Robert D. Odze. (1999). Polypoid dysplasia in Barrett's esophagus: A clinicopathologic, immunohistochemical, and molecular study of five cases. Human Pathology. 30(7). 745–752. 35 indexed citations
20.
Thurberg, Beth L. & Tucker Collins. (1998). The nuclear factor‐κB/inhibitor of kappa B autoregulatory system and atherosclerosis. Current Opinion in Lipidology. 9(5). 387–396. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deeksha Bali Breakdown of academic impact, for papers by Roseline Froissart Breakdown of academic impact, for papers by Maryam Banikazemi Breakdown of academic impact, for papers by Daniel Grinberg Breakdown of academic impact, for papers by Carmelo Rodolico Breakdown of academic impact, for papers by Pei‐Hsin Huang Breakdown of academic impact, for papers by Philippe Latour Breakdown of academic impact, for papers by Grazia M.S. Mancini Breakdown of academic impact, for papers by Shinji Hatakeyama Breakdown of academic impact, for papers by Filippo Pinto e Vairo
Rankless by CCL
2026